EBIT at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's EBIT?
- Crinetics Pharmaceuticals (CRNX) reported EBIT of -$140.38M in Q1 2026.
- How has Crinetics Pharmaceuticals's EBIT changed year-over-year?
- Crinetics Pharmaceuticals's EBIT decreased by 26.0% year-over-year, from -$111.41M to -$140.38M.
- What is the long-term trend for Crinetics Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's EBIT has grown at a 48.0% compound annual growth rate (CAGR), from -$107.7M to -$516.77M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.